News

Expand filters

Filters

Services

Showing 1 - 10 out of 15 results

Patient Stories

A Heart Care Experience to Remember: For a Kansas Citian With a History of Heart Issues, the Proactive, Personable Care at Saint Luke’s Stood Out

Born with congenital heart disease, Christin Murphy, 41, was familiar with cardiology appointments, stress tests, and surgeries.

News

KMBC: New Heart Procedure at Saint Luke’s Gives Hope to Patient With Decades-long Heart Issues

After years of life-threatening cardiac episodes and chest pain, Cindy Mager, 59, became the first Saint Luke's patient to undergo this innovative, life-saving procedure.

Patient Stories

Innovative Heart Failure Device Helps Lawrence Woman Return to Doing What She Loves

When Debbie O’Neal was diagnosed with heart failure at 75, she feared her life was ending. She was the same age that her mother had been when she died of heart disease.

Article

A Simple Test Can Help Determine Your Risk for Heart Attack

For people age 60 or older, or who have a family history of heart disease, one simple test and a matter of minutes can determine the potential risk of a future heart attack.

News

The Wall Street Journal: Heart Attacks Rise During the Super Bowl. You Can Take Precautions.

The Wall Street Journal invited Dr. James O’Keefe, MD, director of preventive cardiology at Saint Luke’s Mid America Heart Institute, to explain the potential risk and share tips on how you can protect your heart during the big game.

News

America's Healthcare Advocate: Women's Heart Health - Who's at Risk for Heart Attack and Stroke?

Dr. Tracy Stevens and Dr. Anna Grodzinsky joined the America's Healthcare Advocate podcast to talk about heart conditions in women.

News

BBC News: Studies Reveal New Effects of Semaglutide

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

Article

American Journal of Managed Care: Semaglutide Enhances Heart Failure Outcomes in Obesity

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

News

Cardiovascular Business: TAVR Linked to Favorable Outcomes for Asymptomatic and Minimally Symptomatic Patients—But is it Necessary?

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

News

Cardiovascular Business: Why Cardiologists Should Pay Close Attention to Rehospitalizations After TAVR or SAVR

Rehospitalization after aortic valve replacement (AVR) is associated with an increased risk of patient mortality, according to new research.